Comparable actions of omalizumab on mast cells and basophils

Treatment with a Combination of Omalizumab and Specific Immunotherapy for Severe Anaphylaxis after a Wasp Sting

(2017) K. Pałgan et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

The role of FcεRI expressed in dendritic cells and monocytes

(2015) Jeoung-Sook Shin et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

The Adaptor 3BP2 Is Required for KIT Receptor Expression and Human Mast Cell Survival

(2015) Erola Ainsua-Enrich et al.   JOURNAL OF IMMUNOLOGY

Three cases of solar urticaria successfully treated with omalizumab

(2015) C. Baliu-Piqué et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Clinical Efficacy and Immunologic Effects of Omalizumab in Allergic Bronchopulmonary Aspergillosis

(2015) Astrid L. Voskamp et al.   Journal of Allergy and Clinical Immunology-In Practice

The effect of omalizumab on small airway inflammation as measured by exhaled nitric oxide in moderate-to-severe asthmatic patients

(2014) M. Asghar Pasha et al.   ALLERGY AND ASTHMA PROCEEDINGS

Proteomics of bronchial biopsies: Galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients

(2014) Pierluigi Mauri et al.   IMMUNOLOGY LETTERS

Rethinking the Role of Immunoglobulin E and Its High-Affinity Receptor: New Insights into Allergy and Beyond

(2014) Barbara Dema et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells

(2014) Alexander Eggel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Immunoglobulin E plays an immunoregulatory role in lupus

(2014) Barbara Dema et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Omalizumab may not inhibit mast cell and basophil activationin vitro

(2014) J. Gericke et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Omalizumab in patients with allergic (IgE-mediated) asthma and IgE/bodyweight combinations above those in the initially approved dosing table

(2014) Oliver Kornmann et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Omalizumab, an anti-immunoglobulin E antibody: state of the art

(2014) Cristoforo Incorvaia et al.   Drug Design Development and Therapy

Omalizumab as a Desensitizing Agent and Treatment in Mastocytosis: A Review of the Literature and Case Report

(2014) Kristin C. Sokol et al.   Journal of Allergy and Clinical Immunology-In Practice

Anti-IgE – emerging opportunities for Omalizumab

(2013) K Suresh Babu et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Effective treatment of idiopathic chronic cold urticaria with omalizumab: Report of 3 cases

(2013) Amandine Le Moing et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Use of Omalizumab in the Treatment of Food Allergy and Anaphylaxis

(2012) Jay A. Lieberman et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy

(2012) Jessica H. Savage et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The Adaptor 3BP2 Is Required for Early and Late Events in Fc RI Signaling in Human Mast Cells

(2012) E. Ainsua-Enrich et al.   JOURNAL OF IMMUNOLOGY

Omalizumab is effective in nonautoimmune urticaria

(2011) Marta Ferrer et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase

(2011) Marcus Maurer et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

CD84 Negatively Regulates IgE High-Affinity Receptor Signaling in Human Mast Cells

(2011) D. Alvarez-Errico et al.   JOURNAL OF IMMUNOLOGY

IgE Mediated Autoallergy against Thyroid Peroxidase – A Novel Pathomechanism of Chronic Spontaneous Urticaria?

(2011) Sabine Altrichter et al.   PLoS One

Mast cell signaling: The role of protein tyrosine kinase Syk, its activation and screening methods for new pathway participants

(2010) Reuben P. Siraganian et al.   FEBS LETTERS

Effects of omalizumab on markers of inflammation in patients with allergic asthma

(2009) S. Holgate et al.   ALLERGY

Efficacy of omalizumab in delayed pressure urticaria: a case report

(2009) C. Bindslev-Jensen et al.   ALLERGY

Fine epitope mapping of humanized anti-IgE monoclonal antibody omalizumab

(2008) Lei Zheng et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Treatment of chronic autoimmune urticaria with omalizumab

(2008) Allen P. Kaplan et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY